Pot Stock Alert: This Company Has the Biggest Upside in 2020

Green Organic Dutchman Holdings Ltd (TSX:TGOD) has huge upside in 2020. Just be careful to note the inherent risks. If you want to get huge cannabis upside, this is your stock.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks have been in a world of pain this year. Nearly every pot stock has been hit hard, with some losing as much as 90% of their value. Once a billion-dollar company, Green Organic Dutchman Holdings (TSX:TGOD) is now valued at just $250 million. In 2020, however, sales could surge to historic levels. And judging by recent data, the cannabis boom is far from over.

This is perhaps the riskiest stock in the industry today. Yet in exchange for that risk, investors get a once-in-a-lifetime opportunity for massive gains. If the company can execute its growth plan, the stock could easily double next year. If the pot market experiences an industry-wide resurgence, the upside could be even higher.

You’ll want to keep this position small given the associated risks, but this lottery ticket might be worth the cost.

Going it alone

Green Organic used to be on top of the cannabis world. Last year, Aurora Cannabis (TSX:ACB)(NYSE:ACB), which was worth $10 billion at the time, purchased nearly one-fifth of the company. Just as importantly, it committed to buying 20% of Green Organic’s output.

In a single deal, Green Organic secured a leading cannabis partner and a cornerstone customer. It was a big vote of confidence in an industry rife with concern. Aurora also agreed to help scale Green Organic’s grow facilities using its world-class consulting arm.

At the time, it seemed as if Green Organic could do no wrong. This year, that all changed after Aurora decided to sell its entire stake (apart from some warrants) while canceling its commitment to purchase 20% of Green Organic’s production.

Today, Green Organic is stuck upstream without a paddle. First production is coming online, and it has zero long-term partners or large customers lined up, at least not anything close to the size of Aurora. It truly is operating as an independent cannabis company.

That’s a dangerous move considering cannabis output is increasingly commoditized, and competitors without the expertise or funding necessary to create in-demand brands will suffer pricing erosion.

With all this bad news, it’s no wonder why TGOD stock has led the cannabis market lower. But if you look closely, there could be a turnaround in the works.

Staging a turnaround

It’s not all bad. As management has noted, Aurora’s purchasing commitment was at wholesale prices. After the deal was canceled, Green Organic is now clear to sell that production at retail prices, increasing the potential for revenue and profit. Of course, the company still needs to prove that it can sell its production at any price.

This year, sales will only total roughly US$12 million. However, two grow facilities are expected to come online at the end of 2019, causing analysts to forecast US$89 million in sales next year. That means the company sells at less than three times earnings. For comparison, Aurora trades at more than double the valuation.

In 2020, if Green Organic can prove that its organic production can successfully sell on the open market, expect that valuation gap to close quickly. No one is sure if this is possible, but that’s why you’re getting a fantastic price. The market is clearly betting against this scenario, but if the Green Organic can move its product in volume, you could earn a 100% return in less than 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »